Issued Patents All Time
Showing 126–143 of 143 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 5620886 | Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas W olfel, Etienne De Plaen | 1997-04-15 |
| 5612201 | Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor | Etienne De Plaen, Bernard Lethe, Jean-Pierre Szikora, Charles De Smet, Patrick Chomez | 1997-03-18 |
| 5610013 | Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors | Benoit Van den Eynde | 1997-03-11 |
| 5591430 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Alan Townsend, Judy Bastin, Pierre van der Bruggen, Pierre Coulie, Thomas F. Gajewski | 1997-01-07 |
| 5589334 | Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor which is processed to an antigen presented by HLA-B44, and uses thereof | Pierre Coulie | 1996-12-31 |
| 5587289 | Isolated nucleic acid molecules which are members of the MAGE-Xp family and uses thereof | Christophe Lurquin | 1996-12-24 |
| 5585461 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Alan Townsend, Judy Bastin, Pierre van der Bruggen, Pierre Coulie | 1996-12-17 |
| 5571711 | Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors | Pierre van der Bruggen, Pierre Coulie, Jean-Christophe Renauld | 1996-11-05 |
| 5558995 | Peptides which are derived from tumor rejection antigen precursor molecule MAGE-1, which complex to MHC molecule HLA-C clone 10, and uses thereof | Pierre van der Bruggen | 1996-09-24 |
| 5554506 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Pierre van der Bruggen, Catia Traversari, Katharina Fleischauer | 1996-09-10 |
| 5554724 | Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof | Cornelis Joseph Maria Melief, M. J. W. Visseren, W. Martin Kast, Pierre van der Bruggen | 1996-09-10 |
| 5541104 | Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1 | Yao-Tseng Chen, Elisabeth Stockert, Yachi Chen, Pilar Garin-Chesa, Wolfgang J. Rettig +2 more | 1996-07-30 |
| 5530096 | Isolated, tyrosinase derived peptides and uses thereof | Thomas Wolfel, Aline Van Pel, Vincent Brichard, Etienne DePlaen, Pierre Coulie +2 more | 1996-06-25 |
| 5519117 | Isolated, tyrosinase derived peptides and uses thereof | Thomas Wolfel, Aline Van Pel, Vincent Brichard | 1996-05-21 |
| 5512444 | Method for determining bladder tumors by assaying for MAGE-1,2,3 or 4 | Jean-Jacques Patard, Francis Brasseur | 1996-04-30 |
| 5512437 | Method for determining head and neck squamous cell carcinomas, prostate carcinomas, and bladder tumors by assaying for mage-3 | Beatrice Gaugler, Benoit Van den Eynde, Etienne DePlaen, Francis Basseur, Bernard Lethe +1 more | 1996-04-30 |
| 5487974 | Method for detecting complexes containing human leukocyte antigen A2 (HLA-A2) molecules and a tyrosinase drived peptide on abnormal cells | Vincent Brichard, Aline Van Pel, Etienne De Plaen, Pierre Coulie, Jean-Christope Renauld +2 more | 1996-01-30 |
| 5462871 | Isolated nucleic acid molecules which encode MAGE derived nonapeptides | Pierre van der Bruggen, Etienne De Plaen, Christophe Lurquin, Catia Traversari, Beatrice Gaugler +1 more | 1995-10-31 |